A national leader in medicine with impeccable credentials, Dr. Makary is imminently qualified to lead the FDA at this ...

Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...

Thousands of people responsible for tracking health trends and disease outbreaks, conducting and funding medical research, ...

The move comes after Secretary Robert F. Kennedy Jr.’s announcement of a sweeping reduction of the Department of Health and ...

It is unclear what will happen to hundreds of pending requests for public information as the health agencies slash staff.

A California company has issued a voluntary recall for a dressing distributed to 18 states and sold under the Trader Joe’s ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

Commissioner Robert Califf said the federal agency that he’s known for years “is finished” after mass layoffs began Tuesday ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

As the biosimilar industry celebrates a decade of growth, the market continues to evolve with expanded treatment options, cost savings, and a flurry of new competitors—yet regulatory challenges, ...